Robustness of Tabular Models Under Natural Distribution Shifts
SSRN Electronic Journal · 2026
DOI: 10.2139/ssrn.6084766 ↗At a glance
Journal article in SSRN Electronic Journal, 2026. Written by Viswatej Seela.
Abstract (original language)
Distribution shift, where the test-time data distribution differs from that of the training data, is a critical challenge in real-world machine learning deployments. This paper presents an empirical study of model brittleness under naturalistic distribution shifts in tabular datasets, a domain that remains understudied despite tabular data being central to applications in finance, healthcare, and public policy. We assess the stability of various machine learning models, including logistic regression, gradient-boosted decision trees, and multilayer perceptrons, in response to deployment-driven shifts that alter feature distributions while maintaining the semantics of the prediction task. In addition to these naturalistic shifts, we implement controlled feature-level perturbations as stress tests. Across five classification datasets, all models exhibit significant performance degradation under distribution shift, with vanilla neural networks generally showing larger robustness gaps than tree-based methods, although these gaps can be substantially reduced by standardization and regularization. The study provides an empirical foundation for understanding robustness trade-offs across model classes in structured data settings and highlights open challenges for robust tabular machine learning
Cite
APA
Seela, V. (2026). Robustness of Tabular Models Under Natural Distribution Shifts. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.6084766
Vancouver
Seela V. Robustness of Tabular Models Under Natural Distribution Shifts. SSRN Electronic Journal. 2026. doi:10.2139/ssrn.6084766
BibTeX
@article{Seela2026,
author = {Seela, Viswatej},
title = {Robustness of Tabular Models Under Natural Distribution Shifts},
journal = {SSRN Electronic Journal},
year = {2026},
doi = {10.2139/ssrn.6084766}
}
EUVIMED